High dose CCK treatment in infants who had undergone major surgeries with resulting parenteral nutrition-associated cholestasis resulted in bilirubin level reduction by about 51.3% when compared to those who had received a lower dose but such had no effect on AST or ALT levels [92]. Here, CCK is linked to cholestasis.